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Abstract Two P-thymosins are expressed in most mammalian 
tissues. We detected small amounts of a third peptide in extracts 
of rabbit spleen. The portion of this peptide increased when the 
tissue was first frozen and then thawed at 4°C. Small amounts of 
the peptide are also present in cells from suspension cultures 
homogenized immediately in diluted perchloric acid. By means of 
amino acid analysis and MALDI-mass spectroscopy this peptide 
was identified to be a C-terminally truncated form of thymosin 
pio. Having studied the formation in more detail we found that 
after a 4-h thaw at 4°C all thymosin Pi0 was truncated to 
thymosin Pio1 415 which was further degraded during the next 20 
h. On the other hand, thymosin p4
A l a , the second P-thymosin 
being present in rabbit spleen, was not truncated or degraded 
even after 22 h. It might be possible that in vivo a truncated form 
of thymosin p10 is formed by a carboxydipeptidase while 
thymosin P4Ala is rather stable against proteolytic modification. 
By using a newly designed ultrafiltration assay, we determined 
the dissociation constants of the complexes of G-actin and these 
three P-thymosins to be 0.28, 0.72, and 0.94 nM for thymosin 
P4Ala, Pio, and thymosin Pio1 41, respectively. The complex 
with p4
A l a is unambiguously more stable than the complex with 
Pio or p4 (0.81 nM). The change in the dissociation constant 
generated by the truncation of the two C-terminal amino acid 
residues of Pio is small but statistically significant. This 
demonstrates that even the very last amino acid residues at the 
C-terminus of P-thymosins are involved in the interaction with 
G-actin. 
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1. Introduction 
Thymosin P4 has first been described as a thymic hormone 
from calf thymus [1,2]. Thymosin P4 is accompanied by a 
second highly homologous peptide, thymosin p8 [3] when iso-
lated from thymosin fraction 5. Extraction of peptides from 
calf thymus with guanidinium hydrochloride denaturing pro-
teases immediately led to the isolation of thymosin p9 which is 
identical to thymosin p8 with the exception of an additional 
dipeptide at the C-terminus [3]. The isolation of thymosin P4 
and homologous peptides, which are called thymosin f34-like 
peptides or p-thymosins, from various cells [4,5] and tissues of 
vertebrates [6-8] in high concentrations shaded doubts on 
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their function as thymic hormones. Later on Safer et al. [9] 
isolated a G-actin sequestering factor, Fx, and showed that 
this factor is identical to thymosin P4 [10]. The query that 
nearly all mammalian tissues investigated up to now express 
two members of this family has not been clarified [11,12]. 
Most recently a third P-thymosin (p15) has been detected in 
Dunning rat prostate carcinoma additionally to thymosin p4 
and Pio [13]. In tissues of rabbit [7,14] and trout [15,16] two P-
thymosins are found in comparable concentrations. Rabbit 
spleen contains thymosin p4
Ala and Pi0 whereas in the spleen 
of trout thymosin Pn and Pi2-trout are present. 
Weber et al. [17] determined the dissociation constant for 
the interaction of thymosin p4 with G-actin by measuring the 
increase in fluorescence of pyrenyl-labeled actin when poly-
merizing to filamentous F-actin. Jean and coworkers [18] em-
ployed the change in tryptophan fluorescence of actin to de-
termine the interactions with thymosin P4 and PgMel. 
However, this method is restricted to those p-thymosins pos-
sessing a methionyl residue. In the case of interactions with p-
thymosins which do not contain a methionyl residue, or when 
the methionyl residue is oxidized, only a very weak change in 
fluorescence intensity could be detected by the authors. Heintz 
et al. [19] also studied actin-P-thymosin interactions under 
non-polymerizing conditions by employing G-actin which 
was modified by monobromotrimethylammoniobimane bro-
mide. In a previous paper we introduced an equilibrium cen-
trifugation assay to study the interactions of P-thymosins and 
their fragments with non-modified G-actin [20]. This excludes 
a possible influence of the fluorescent reporter group, as has 
been demonstrated by Giuliano and Taylor for the interaction 
of G-actin with profilin [21]. In this paper we report that a C-
terminally truncated form of thymosin p ] 0 is present in rabbit 
spleen and a human alveolar cell line. The C-terminal trunca-
tion changes the interaction with G-actin as shown by a newly 
designed, efficient and manageable ultrafiltration assay. 
2. Materials and methods 
2.1. Materials 
Reagents were obtained from the following sources: LiChroprep 
RP-18 (40-63 urn) and trifluoroacetic acid (TFA, Uvasol) from Merck 
(Darmstadt); ovalbumin from Sigma and fluorescamine from Serva. 
2.2. Proteins and peptides 
Actin was prepared from bovine heart muscle by the method of 
Pardee and Spudich [22] and further purified by gel-filtration [23] 
on a Sephacryl S300 column (Pharmacia) equilibrated with G-buffer 
(2 mM Tris-HCl, 0.2 mM ATP, 0.2 mM CaCl2, 0.5 mM mercapto-
ethanol, 0.05% NaN3, pH 8.0). Pyrene-labeled actin was prepared 
according to Kouyama and Mihashi [24]. G-actin was stored in G-
buffer at 0°C. The peptides were isolated from rabbit spleen according 
to the method described for thymosin PoMct from pork spleen [25]. 
The purity of the preparations was demonstrated by reverse-phase 
high-performance liquid chromatography (RP-HPLC). The concen-
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00946-0 
40 T. Huffet allFEBS Letters 414 (1997) 39-44 
trations of P-thymosins and actin were determined by amino acid 
analysis after acid hydrolysis (6 M HC1, 155°C, 1 h) and precolumn 
derivatization with o-phthaldialdehyde/3-mercaptopropionic acid [26], 
2.3. Time course ofproteolytic degradation 
Six freshly prepared rabbit spleens were frozen in separate tubes for 
24 h and then thawed for 0, 0.5, 1, 2, 4 or 22 h at 4°C. Thereafter, the 
spleens were homogenized in four volumes of ice-cold 0.4 M PC A and 
a defined amount of the dipeptide Phe-Phe (5 ug/g tissue) was added 
as an internal standard. After 30 min on ice the extracts were centri-
fuged for 5 min at 20 000 Xg. The supernatant solution was carefully 
removed and adjusted to pH 4 with 10 M KOH. After another 30 min 
on ice the precipitated KCIO4 was removed by centrifugation and an 
aliquot of the supernatant was analyzed by RP-HPLC. 
2.4. HPLC 
Chromatographic conditions were controlled by a Merck-Hitachi 
L-6200 system supplemented with an reaction pump for post-column 
derivatization (655A-13, Merck-Hitachi) and with a fluorometer (F-
1050, Merck-Hitachi). The fluorescence signal was recorded on an 
integrator (D-2500, Merck-Hitachi). 
2.4.1. Analytical separations. Flow rate was 0.75 ml/min. The 
buffer was 0.1% TFA; gradients are as described in figure legends. 
The column was a Beckman ODS Ultrasphere (5 um, 4.6x250 mm). 
For detection post-column derivatization with fluorescamine was 
used. 
2.4.2. Preparative separation of the peptides. Flow rate was 0.75 
ml/min. The buffer was 0.1% TFA. The gradient was linear from 0 to 
40% acetonitrile in 120 min. The column was a Pharmacia SuperPac 
Pep-S (5 um, 4x250 mm); detection was at 215 nm (UV-detector L-
4000, Merck-Hitachi). 
2.5. Matrix-assisted laser desorption mass spectrometry 
(MALDI-MS) 
Mass determinations were performed with a LaserTec Research 
time-of-flight mass spectrometer (Perseptive Biosystems, USA). The 
instrument is equipped with a nitrogen laser (k = 337 nm, pulse dura-
tion 3 ns, 20 pulses/s). Laser-desorbed positive ions were analyzed 
after being accelerated by 20 kV resulting in a mass range for single 
charged ions up to 5.6 kDa in the reflection mode. External calibra-
tion was performed by using [M+H+]+ of melittin (Mr = 2847.5). 
Usually 40^80 laser shots were averaged to produce a mass spectrum. 
2.6. Sample preparation for MALDI-MS 
Pep tide samples were diluted with H 2 0 to a concentration of about 
5-20 pmol/ul. As matrix solution, 10 mg of oe-cyano-4-hydroxy-cin-
namic acid were dissolved in 1 ml containing 33.3% acetonitrile and 
0.1% TFA. Equal volumes of analyte solution and matrix solution 
were mixed and 2 ul of the mixture were pipetted onto the roughened 
2.5-mm diameter sample positions on a stainless-steel plate. 
solutions of F-actin containing a constant amount of the P-thymosin. 
These experiments were done in a buffer consisting of 2 mM MgCk, 2 
mM Tris-HCl, 0.2 mM ATP, 0.2 mM CaCl2, 0.5 mM mercaptoetha-
nol and 0.05% NaN3, pH 8.0. 
2.9. Calculation of dissociation constants 
For an interacting system like G-actin (G) and P-thymosin (PT): 
G + PT^G-pT 
The dissociation constant can be calculated by applying the following 
equation: 
[PT]fae-[G]tree 
K< d,app : [G-pT] (1) 
where K^aw
 = apparent equilibrium constant; [G-PT]=concentration 
of formed complex; [G]free = concentration of unbound G-actin and 
[PT]free = concentration of unbound P-thymosin, which can be deter-
mined from the following equation: 
[pT]free = [pT]-
- |3T 
where [PT]=concentration of P-thymosin before centrifugation; 
concentration of peptide in ultrafiltrate 
concentration of peptide before ultrafiltration 
(2) 
(3) 
and FpT = in the presence of G-actin and F'pT = in absence or in 
presence of ovalbumin after being proven that there is no interaction 
between thymosin p4 and ovalbumin (data not shown). The concen-
tration of the complex [G-PT] can be calculated from the following 
equation: 
[G-PT] = [pT]-[PT]frcc (4) 
and the value for the concentration of unbound actin [G]free can be 
calculated from 
[G]free = [G]-[G-PT] (5) 
where [G] is the total concentration of actin before centrifugation. 
3. Results 
3.1. Isolation and characterization of thymosin Pio1'^1 
When we analyzed perchloric acid extracts of freshly iso-
lated rabbit spleens by R P - H P L C to determine their content 
of P-thymosins, we detected a third peptide eluting between 
the expected two P-thymosins (Fig. 1). We also observed that 
the portion of this peptide increased when spleens where first 
2.7. Determination of Kj values by ultrafiltration 
A defined amount of the internal standard Phe-Phe was added to 
thymosin P4Ala, thymosin Pi0, or thymosin Pio
1-41 and diluted to a 
concentration of 60 uM. This solution was diluted 4-fold with either 
G-buffer or a solution of G-actin (0.86 mg/ml) or ovalbumin (0.9 mg/ 
ml). The first pair of ultrafiltration units (Nanosep 30 kDa, Pall Fil-
tron Corporation, North Borough, MA 01532, USA) was loaded with 
100 ul of the pep tide-buffer mixture, the second pair with 100 JJ.1 of 
peptide-actin solution and the third pair with 100 ul of peptide-oval-
bumin mixture. All tubes were incubated for 15 min at room temper-
ature and then centrifuged for 15 min at 2700 Xg in a table-top 
centrifuge (Eppendorf centrifuge 5417, Eppendorf-Netheler-Hinz, Ger-
many). Ultrafiltrates (40 ul) were analyzed by HPLC. 
2.8. Determination of Kj values using pyrenyl-actin 
To determine the concentration of unpolymerized actin being the 
sum of the critical concentration of G-actin plus the G-actin seques-
tered by P-thymosin, the polymerization of actin in the absence or 
presence of p-thymosins was determined using native actin supple-
mented with 5%. of pyrenyl-actin according to Weber et al. [17]. Ex-
citation and emission wavelengths were set at 365 and 386 nm, re-
spectively, using a Kontron fluorometer (SFM 25). In presence of p-
thymosins the amount of unpolymerized actin in equilibrium with F-
actin was derived from fluorescence measurements of serially diluted 
Table 1 
Amino acid composition of the three P-thymosins isolated from rab-
bit spleen 
Residue" Thymosin P4Ala Thymosin Pn 
Asx 
Glx 
Ser 
Gly 
Thr 
Arg 
Ala 
Met 
He 
Phe 
Leu 
Lys 
4.1 (4)b 
10.3 (11) 
2.0 (3) 
1.1 (1) 
2.7 (3) 
0.0 (0) 
3.3 (3) 
0.3 (1) 
2.3 (2) 
0.9 (1) 
2.3 (2) 
8.1 (9) 
4.3 (4)b 
8.4 (9) 
2.1 (3) 
1.3 (1) 
4.1 (5) 
0.8 (1) 
3.3 (3) 
0.3 (1) 
3.1 (3) 
0.8 (1) 
2.2 (2) 
7.6 (8) 
4.2 (4)c 
8.7 (9) 
1.2 (2) 
1.3 (1) 
3.9 (5) 
0.6 (1) 
3.0 (3) 
0.3 (1) 
2.1 (2) 
0.8 (1) 
2.0 (2) 
7.1 (8) 
aProline was not determined, all other amino acids not listed were 
<0.1 residue per peptide. 
bValues in parentheses are from the known sequences of thymosin 
p4
Ala [7] and thymosin p10 [14,30-32]. 
cValues in parentheses are from the sequence of thymosin pio1-41 
reported here. 
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Fig. 1. HPLC analysis of the PCA-extract of rabbit spleen. An ali-
quot (100 u.1) of the PC A extract after neutralization was analyzed 
by RP-HPLC on a Beckman ODS Ultrasphere column. Peptides 
were eluted with the following gradient: 0-16% acetonitrile in 0.1%. 
TFA in 10 min and from 16 to 40%> during 90 min. Detection was 
carried out by post-column derivatization with nuorescamine [29]. 
Retention time (min): thymosin p4Ala 
(39.5); thymosin p10 (40.7). 
(38.0); thymosin P41 
frozen and then thawed at 4°C, whereas the portion of thy-
mosin pio decreases. This was a first hint that the unknown 
peptide may derive from thymosin (310. We used a freeze-thaw 
cycle to generate higher amounts of this peptide for the iso-
lation and characterization of the unknown peptide. All three 
peptides were isolated using the protocol described under Sec-
tion 2. Afterwards we determined the amino acid composition 
of the unknown peptide by total acid hydrolysis. We found 
that the amino acid composition of the unknown peptide is 
nearly identical to that of thymosin fi10 except that it con-
tained one serine and one isoleucine residue less than thymo-
sin (310 (Table 1). The comparison of the amino acid compo-
sition with the known amino acid sequence of thymosin Pio 
suggested that the unknown peptide might be a C-terminally 
truncated form of thymosin (3i0. To verify this, we employed 
MALDI-MS to determine the molecular mass of all three 
isolated peptides. As shown in Fig. 2 the molpeak [M+H+J+ 
for protonated thymosin p4Ala appeared at a molecular mass 
of 4947.8 (m/z) (Fig. 2A), the molpeak for thymosin pi0 at 
4937.6 (Fig. 2B) and [M+H+]+ for the unknown peptide at 
4734.5 (Fig. 2C). The small peak at 4933.9 in the spectra of 
the unknown peptide represents a small amount of contami-
nation with thymosin Pio. Table 2 summarizes observed and 
calculated molecular masses of the three peptides. These data 
substantiated that the unknown peptide represented thymosin 
Pio truncated for two amino acid residues at the C-terminus. 
This peptide is named thymosin Pio1"41. 
Further studies of the time course of proteolytic degrada-
tion showed that after a 4-h incubation period thymosin pio 
was completely converted to thymosin pio1"41. Thymosin 
Pi disappeared almost completely after a thaw of 22 h, 
whereas the amount of thymosin p4
Ala remained constant 
(data not shown). 
3.2. Detection of thymosin pio1^^1 in cells from suspension 
culture 
To verify that this peptide is also present in cells from 
suspension culture, we analyzed several cell lines after imme-
diate homogenization in diluted perchloric acid. In all cases a 
small peak between thymosin P4Ala and thymosin Pio was 
present. As an example Fig. 3 shows the HPLC chromato-
gram of a perchloric acid extract from the human alveolar cell 
line A549. To confirm that this peak represents thymosin 
Pio1"41, we collected the HPLC eluate between 38 and 41 
min, containing thymosin p4 and the unknown peptide, but 
excluding thymosin Pio. This eluate was then analyzed by 
MALDI-MS. As expected, the mass spectra shows a large 
peak at 4946.3, representing thymosin P4 and a small peak 
at 4737.1 representing thymosin pio1"41 (Fig. 4). 
3.3. Determination of dissociation constants 
To study the influence of C-terminal truncation on the in-
teraction with G-actin in the absence of a fluorescent reporter 
group in G-actin and under non-polymerizing conditions, we 
developed an ultrafiltration assay. Depending on the differ-
ence in molecular mass between the P-thymosins (5 kDa) 
and their complexes with actin (48 kDa), one can separate 
by ultrafiltration free P-thymosin from P-thymosin complexed 
with actin. The amount of free P-thymosin can be determined 
Table 2 
Characterization of isolated peptides 
Thymosin P4Ala 
Thymosin p10 
Thymosin Pio1"41 
Composition 
[M+H+]+ 
[M+H+]+ 
[M+H+]+ 
m/e 
(observed) 
4947.8 
4937.6 
4734.5 
(calculated) 
4948.9 
4938.0 
4738.7 
Deviation in %o 
0.22 
0.08 
0.89 
Molecular mass of the purified peptides [M+H+]+ were determined by MALDI-MS. 
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Fig. 2. MALDI mass spectra of the isolated peptides: (A) thymosin B4
Ala, [M+H+]+ identification: m/z 4947.8; (B) thymosin p10, [M+H
+]+ 
identification: m/z 4937.6; (C) thymosin pu [M+H+]+ identification: m/z 4734.5. 
by analyzing the ultrafiltrate by RP-HPLC. We were inter-
ested to investigate whether the truncation of thymosin p10 
to thymosin Pio1-41 influences its interaction with G-actin. 
Therefore, we determined the dissociation constants for these 
two peptides from rabbit spleen and also for thymosin p4 and 
p4
Ala with the described ultrafiltration assay. The difference in 
the Ki value of the complex of G-actin with thymosin Pi0 and 
thymosin f310
1-41 is small, but statistically significant (Student 
Mest, 2P< 0.001) and comparable to the dissociation con-
stant of the G-actin-thymosin p4 complex. In contrast the 
Kd value of the complex with thymosin P4Ala was about 3-
fold lower (0.28 |iM). For validation of the ultrafiltration 
method, we compared the obtained data with the data ob-
tained by using pyrenyl-labeled G-actin (Table 3). 
Table 3 
Comparison of the apparent dissociation constants for the interaction between G-actin and P-thymosins 
Thymosin 
P 4
A l a 
Pio 
Pio1"41 
•Kd,app ( U M ) 
Determined by ultrafiltration 
(jc±SD) 
0.28 ±0.03 
0.81 ±0.11 
0.72 ±0.09 
0.94 ±0.06 
(») 
Determined by pyrenyl-labeled actin 
(jc±SD) 
7 
9 
5 
4 
0.28 ±0.04 
0.75 ±0.06 
0.66 
0.80 
3 
3 
The apparent dissociation constants for the interaction between P-thymosins and G-actin from bovine heart were determined by ultrafiltration 
assay or with pyrenyl-labeled actin. The exact concentrations of P-thymosin and actin were estimated by amino acid analyses before use. All assays 
were carried out with a single actin preparation. 
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4. Discussion 
In 1981 Low et al. reported the isolation and sequence 
analysis of a peptide from thymosin fraction 5 which they 
named thymosin p4 [1]. A year later we characterized a second 
highly homologous peptide in thymosin fraction 5, thymosin 
Ps [3]. However, when we treated calf thymus with guanidi-
nium hydrochloride, which minimizes proteolytic activity dur-
ing preparation, we isolated another peptide that was identical 
to thymosin Pg with the exception of an additional dipeptide 
at the C-terminus [3]. Therefore, we concluded that thymosin 
ps was proteolytically generated probably during the prepara-
tion of thymosin fraction 5 [3]. In the following years several 
reports showed the ubiquitous distribution of high intracellu-
lar concentrations of thymosin p4 and several homologous 
peptides [4-8]. Nevertheless, no information on proteolytic 
modifications of p-thymosins has been reported. Safer et al. 
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Fig. 3. HPLC analysis of the PCA extract of A549 cells. About 
5X106 cells were homogenized in 400 (il of 0.4 M perchloric acid. 
After 30 min at 4°C and centrifugation for 5 min at 14000Xg the 
supernatant was adjusted to pH 4 using 10 M KOH. The precipi-
tated KCIO4 was removed by centrifugation and the supernatant 
was analyzed by RP-HPLC with conditions as described in the 
legend to Fig. 1. Retention time (min): thymosin p4 (38.3); thymo-
sin pio1"41 (40.5); thymosin p10 (41.7). 
Fig. 4. MALDI mass spectra of the HPLC eluate from A549 cells. 
Eluate of HPLC run between 38 and 41 min was collected, dried in 
a speed-vac and further treated as described in Section 2. 
[9] and Weber et al. [17] found that the main physiological 
role of thymosin P4 seems to be the sequestering of actin 
monomers. In most mammalian tissues investigated, two p-
thymosins are expressed, whereby in most cases thymosin p4 is 
the main peptide which represents about 70-80% of the total 
P-thymosin content. One of the two known exceptions is rab-
bit spleen in which thymosin p4
Ala and thymosin Pi0 were 
found in comparable amounts. Our finding that in rabbit 
spleen and several cell lines a small portion of thymosin Pio 
is truncated at the C-terminus for two amino acids, is the first 
report of a proteolytic modification of P-thymosins. We also 
showed that when the tissue is first frozen and then thawed at 
4°C for 2 h almost all thymosin Pio was truncated to thymosin 
Pio1-41, which was then further degraded during the next 20 h. 
Thymosin p4
Ala , the second P-thymosin, expressed in rabbit 
spleen was not degraded under these conditions at all. The 
demonstration, that small amounts of thymosin Pio1-41 are 
present in cells aside from Pio is important when studying 
the concentration or distribution of thymosin Pio by antibod-
ies. The antibodies may recognize thymosin Pio as well as the 
truncated thymosin pio1"41. 
Several groups studied the interaction of actin and P-thy-
mosin by labeling actin at Cys374 with various fluorescent 
reporter groups [17-19,27,28]. These methods are bound of 
the following restrictions and disadvantages. Some of them 
can only be used at salt conditions that initiate actin polymer-
ization and can, therefore, only be used to study interactions 
with peptides that inhibit actin polymerization. Labeling of 
actin can interfere with the interaction of actin with P-thymo-
sins and some methods are restricted to those P-thymosins 
containing a methionine residue. In a previous paper [20], 
we introduced an equilibrium centrifugation assay, which 
did not require any derivatization of actin and can be used 
at low salt concentrations. This enabled us to determine dis-
sociation constants of N-terminally truncated P-thymosins, 
which do not inhibit actin polymerization. This method, how-
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ever, has the disadvantage that a calibration curve with mo-
lecular mass standards in the used molecular weight range had 
to be generated and that one equilibrium centrifugation run 
consumed at least 16 h. Therefore, we established an ultra-
filtration assay, which can be efficiently and easily handled 
and is carried out with non-labeled G-actin. The method is 
based on the work of Sophianopoulos and coworkers [33,34], 
who showed that during ultrafiltration of a system at equili-
brium, although the concentration of the macromolecule-li-
gand complex increases, the total amount of it in the ultra-
filtration cell remains constant. Since no net uptake or 
removal of ligand takes place, the rate of the filtrate does 
not disturb the equilibrium. Free (3-thymosin can be separated 
from actin-bound (3-thymosin by employing ultrafiltration 
tubes equipped with a 30-kDa cut-off membrane and an ad-
justable tabletop centrifuge. The concentration of free (3-thy-
mosin can then be determined by H P L C analysis of the ultra-
filtrate. The dissociation constant of the actin-|3-thymosin 
complex can be calculated knowing the initial concentrations 
of P-thymosin and actin. The values obtained by this simple, 
fast and economic ultrafiltration procedure are in good agree-
ment with our values observed after overnight incubation of 
(3-thymosins with pyrenyl-labeled G-actin and we therefore 
conclude, that the equilibrium is reached during ultrafiltra-
tion. 
The complex of G-actin with thymosin p 4 is stabilized when 
the N-terminally acetylated seryl residue is replaced by an 
alanyl residue (P4Ala) as it is the case in rabbit tissues. While 
the N-terminus is strongly involved in the interaction with G-
actin, the two C-terminal amino acid residues seem to be less 
important for the interaction. However, even the removal of 
only these two amino acid residues generate a small but stat-
istically significant increase in the dissociation constant of the 
complex with G-actin. This suggests that the small p-thymo-
sins interact in their entire length with G-actin. 
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